Our Founding Background

Founded in March 2023 in Boston, USA, BioSynth Innovations Inc. aims to address data silos and security challenges in bioscience, leveraging blockchain to advance global applications of synthetic biology and gene editing.

Integration of Blockchain and Bioscience

We utilize Solana’s high-performance, low-cost blockchain to build a decentralized biological data platform, enabling secure storage, trading, and research collaboration to accelerate innovation from lab to market.

Data Security Strategy

BSY employs post-quantum cryptographic algorithms (e.g., lattice-based encryption) and distributed storage to ensure the long-term security of genomic and experimental data, complying with global privacy laws like HIPAA and GDPR.

Research Collaboration Mechanisms

Through smart contracts and a decentralized autonomous organization (DAO), BSY automates data sharing, intellectual property allocation, and result validation, fostering cross-disciplinary global research collaboration.

Technical Architecture Advantages

Built on Solana’s Proof of History (PoH) and Proof of Stake (PoS) consensus, BSY achieves tens of thousands of transactions per second, significantly reducing data processing and storage costs.

Team Expertise

Our team comprises top experts in molecular biology, computer science, and financial compliance, including Oxford PhD Victoria Kline and blockchain developer Miles Thornton, with extensive cross-domain experience.

Social Impact Commitment

BioSynth allocates 10% of BSY transaction fees to bioscience education programs and supports environmental sustainability via Solana’s low-energy blockchain, contributing to global health and education.

Global Compliance Practices

BSY adheres to anti-money laundering (AML) and know-your-customer (KYC) requirements, complying with regulations like HIPAA and GDPR to ensure transparent, legal operations across global jurisdictions.

Vision and Market Positioning

BSY aims to lead decentralized bioscience technology, bridging academia and the biotech industry to address critical challenges in human health, food security, and environmental sustainability.

User Empowerment Goals

BSY offers user-friendly mobile and web interfaces compatible with Solana ecosystem wallets (e.g., Phantom), lowering barriers for small research institutions and individual users to engage in cutting-edge research.

BioSynth’s Core Values and Commitments

• Innovation-Driven: BioSynth integrates blockchain with synthetic biology to develop groundbreaking technical solutions, revolutionizing biological data management and research collaboration, unlocking unprecedented efficiency and possibilities for global bioscience.
• Security First: Employing post-quantum cryptographic algorithms and decentralized storage, BSY ensures the absolute security of high-value biological data like genomic sequences and clinical trial data, safeguarding against future quantum computing threats while complying with stringent privacy standards like HIPAA and GDPR.
• Transparent Collaboration: Leveraging Solana’s publicly verifiable blockchain, BSY establishes trust through smart contracts and DAO governance, facilitating seamless data sharing and collaboration among research institutions, biotech companies, and individual users.
• Global Accessibility: Utilizing Solana’s low-cost and high-throughput capabilities, BSY reduces data processing and storage costs, enabling small research institutions and independent researchers to participate equitably in cutting-edge biotech research, breaking down resource barriers.
• Sustainable Impact : Committed to environmental and social responsibility, BioSynth minimizes carbon footprints via Solana’s low-energy blockchain and allocates 10% of transaction fees to bioscience education and global health initiatives, supporting sustainable development goals.
• Industry Empowerment : BSY provides decentralized finance (DeFi) tools for research crowdfunding and result tokenization, helping researchers transform scientific discoveries into commercial value, accelerating the transition of biotech innovations from lab to market.

Join BioSynth’s Bioscience Revolution

BioSynth Innovations Inc., through its BioSynth (BSY) project, leverages Solana’s blockchain to reshape bioscience. We invite global research institutions and researchers to join us in building a secure, collaborative bioscience ecosystem, addressing data security and collaboration challenges, and accelerating synthetic biology and gene editing innovations to tackle human health and environmental issues.